Search Results - "Cirilli, N"

Standards of care guidance for sweat testing; phase two of the ECFS quality improvement programme by Cirilli, N., Southern, K.W., Barben, J., Vermeulen, F., Munck, A., Wilschanski, M., Nguyen-Khoa, Thao, Aralica, M., Simmonds, NJ, De Wachter, E.

“…•Surveys in Europe still highlight inconsistencies in the performance and reporting of sweat tests in Europe.•A practical tool helps CF centres/labs to improve…”
Get full text

Real life practice of sweat testing in Europe by Cirilli, N., Southern, K.W., Buzzetti, R., Barben, J., Nährlich, L., Munck, A., Wilschanski, M., De Boeck, K., Derichs, N.

“…Evidence based guidelines exist for sweat testing, which remains a key component of a diagnosis of cystic fibrosis (CF), especially following newborn bloodspot…”
Get full text

111 Non-tuberculous mycobacteria in patients with cystic fibrosis: detection and isolation from respiratory samples. Results of a cross-sectional study by Fabrizzi, B, Caporelli, N, Cirilli, N, Lazarte, A.G, Masseria, F, Cipolli, M

Get full text

282 Patient priorities for research in cystic fibrosis: the IPaCOR experience by Cirilli, N, Buzzetti, R, Costa, S, Magazzù, G

Get full text

281 Patient-centered outcomes in CF research by Cirilli, N, Buzzetti, R, Costa, S, Magazzù, G

Get full text

62 Molecular diagnosis of Pseudomonas aeruginosa infection in culture-negative samples from cystic fibrosis patients by Amiri, M, Mangiaterra, G, Pasquaroli, S, Vignaroli, C, Cirilli, N, Manso, E, Biavasco, F

“…Pseudomonas aeruginosa infection is the main cause of morbidity and mortality in cystic fibrosis (CF) patients. Cultural methods, the gold standard for…”
Get full text

WS11.4 Real life practice of sweat testing in Europe: results from an ECFS-wide survey by Cirilli, N, Buzzetti, R, Southern, K.W, Barben, J, Nährlich, L, Munck, A, Wilschanski, M, De Boeck, K, Derichs, N

Get full text

428 Are cystic fibrosis guidelines credible? Evaluating methodological issues by Terlizzi, V, Cirilli, N, Galici, V, Neri, A.S, Baldo, E, Dinella, G, Guerzoni, C, Turrin, V, Adami, A, Buzzetti, R, Braggion, C

Get full text

WS10.6 Intra-individual biological variation in sweat chloride concentrations by Cirilli, N, Raia, V, De Gregorio, F, Di Pietro, M, Tosco, A, Salvadori, L, Sepe, A, Buzzetti, R, Minicuci, N, Rocco, I, Castaldo, G, Nardiello, P

Get full text

A randomized placebo-controlled study on high-dose oral algal docosahexaenoic acid supplementation in children with cystic fibrosis by Alicandro, G, Faelli, N, Gagliardini, R, Santini, B, Magazzù, G, Biffi, A, Risé, P, Galli, C, Tirelli, A.S, Loi, S, Valmarana, L, Cirilli, N, Palmas, T, Vieni, G, Bianchi, M.L, Agostoni, C, Colombo, C

“…Abstract Low plasma concentrations of docosahexaenoic acid (DHA) are reported in unsupplemented cystic fibrosis (CF) patients. Forty-one CF patients aged from…”
Get full text

26 Risk factors for poor outcomes in cystic fibrosis newborns diagnosed by neonatal screening in Italy: years 2009–2011 by Repetto, T, Buzzetti, R, Cirilli, N, Padoan, R, Piccinini, P, Vecchini, I, Zavataro, L

Get full text

P017 Sweat test: different clinical questions require different lab reports by Cirilli, N., Dolce, D.

Get full text

20 Cystic fibrosis newborn screening in Italy: survey for assessment of technical-scientific and organizational issues by Repetto, T, Cirilli, N, Corbetta, C, Padoan, R, Piccinini, P, Zavataro, L, Buzzetti, R

Get full text

WS21.3 Clinical variability in patients with cystic fibrosis and D1152H mutation by Terlizzi, V, Ingino, R, Elce, A, Tosco, A, Improta, F, Cirilli, N, Gagliardini, R, Salvatore, D, Carnovale, V, D'Agostino, M.A, Sepe, A, Amato, N, De Gregorio, F, Casale, A, Raia, V, Castaldo, G

Get full text

10 The role of complex alleles in patients with cystic fibrosis and L997F by Cirilli, N, Terlizzi, V, Nardiello, P, Gagliardini, R, Tosco, A, Sepe, A, Quarta, B.M, Amato, N, Improta, F, Romano, R, De Gregorio, F, Casale, A, Carnovale, V, D'Agostino, M.A, Raia, V, Castaldo, G

Get full text

290 Oral DHA supplementation in children with cystic fibrosis: a randomized placebo-controlled study by Alicandro, G, Gagliardini, R, Santini, B, Rise', P, Biffi, A, Tirelli, A.S, Tiso, R.M, Valmarana, L, Cirilli, N, Colombo, C

Get full text

P477 How the use of nocturnal non-invasive ventilation and oxygen therapy changes in patients with cystic fibrosis using elexacaftor/tezacaftor/ivacaftor by Luciani, L., Peruzzi, A., Cirilli, N., Caporelli, N., Fabrizzi, B.

Get full text

P261 Detection of viable but non culturable Stenotrophomonas maltophilia in cystic fibrosis sputum samples: evidence and perspectives by Cirilli, N., Mangiaterra, G., Schiavoni, V., Fabrizzi, B., Biavasco, F.

Get full text

P040 Sweat chloride values in cystic fibrosis patients after one year on elexacaftor/tezacaftor/ivacaftor by Cirilli, N., D’Antuono, A., Masseria, F., Caporelli, N., Fabrizzi, B.

Get full text

Pseudomonas aeruginosa (PA) resistant to colistin (CL) in Italian cystic fibrosis (CF) patients by Manno, G, Morelli, P, Mentasti, M, Casciaro, R, Cirilli, N, Gagliardini, R, D'Aprile, A, Gioffrè, F, Scuteri, D, Melioli, G

Get full text